Benchmark Monitor
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been granted approval by the Food and Drug Administration for Soliris. Soliris (eculizumab) is an injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), a Healthcare sector firm, traded 1.01 Million shares in last trading session with closing price of $126.11 per share. […]
PepsiCo, Inc. (NASDAQ:PEP) facing an industrywide backlash against plastic, will experiment with putting its Aquafina water in cans. The beverage giant will begin selling the cans next year, offering them to partners such as stadiums and restaurants, PepsiCo said June 27. The company also will try out the repackaged product at some retail stores. PepsiCo, Inc. (NASDAQ:PEP), […]
Nordstrom, Inc. (NYSE:JWN) and Rent the Runway announced a partnership that aims to draw more foot traffic into the department store while making the clothing rental service more convenient so it can improve service to existing customers and attract new ones. Nordstrom, Inc. (NYSE:JWN), a Services sector firm, traded 5.48 Million shares in last trading […]
A further deterioration in relations between the U.S. and China could set off a chain of events that would push oil down more than 50% to as low $30 a barrel, according to Bank of America Corporation (NYSE:BAC) Merrill Lynch. President Donald Trump may decide to raise tariffs on the remaining $300 billion of Chinese […]